Trial intelligence / Profile preview

Safety and Immunogenicity of H5N1 Vaccine in Children

NCT00491985Phase 2Completed

Sponsor
Sanofi
Start
Jun 2007
Primary completion
Dec 2009
Modality
Split/Subunit Vaccines, Whole Inactivated Vaccines
Countries
1
01

Overview

A Phase 2 trial of Influenza A (H5N1) vaccine in Influenza A H5N1 (H5N1), sponsored by Sanofi. Started Jun 2007; status: completed.

02

Drugs

Influenza A (H5N1) vaccine
03

Conditions

Influenza A H5N1 (H5N1)

Beyond the preview

Go deeper on NCT00491985.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00491985.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call